Identification of CD166 as a surface marker for enriching prostate stem/progenitor and cancer initiating cells

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Jiao, Jing ^a,b   Hindoyan, Antreas ^a,b   Wang, Shunyou ^a,d   Tran, Linh M ^a,b   Goldstein, Andrew S ^b   Lawson, Devon ^a   Chen, Donghui ^b   Li, Yunfeng ^a,b   Guo, Changyong ^b   Zhang, Baohui ^b   Fazli, Ladan ^c   Gleave, Martin ^c   Witte, Owen N ^a,b   Garraway, Isla P ^b   Wu, Hong ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d Intellikine Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER GROWTH; CASTRATION; CASTRATION RESISTANT PROSTATE CANCER; CELL STRUCTURE; CELL SURFACE; CONTROLLED STUDY; GENE DELETION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PROSTATE; STEM CELL; UPREGULATION;

ACTIVATED-LEUKOCYTE CELL ADHESION MOLECULE; ANIMALS; CASTRATION; CELL MEMBRANE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EPITHELIUM; GENE DELETION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE; NEOPLASTIC STEM CELLS; PROSTATE; PROSTATIC NEOPLASMS; PTEN PHOSPHOHYDROLASE; REGENERATION; SPHEROIDS, CELLULAR; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

MURINAE;

EID: 84864571560     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042564     Document Type: Article

References (59)

1. Jemal A, Siegel R, Xu J, Ward E, (2010) Cancer statistics, 2010. CA Cancer J Clin 60: 277-300.
2. Taylor RA, Toivanen R, Risbridger GP, (2010) Stem cells in prostate cancer: treating the root of the problem. Endocr Relat Cancer 17: R273-285.
3. Wang ZA, Shen MM, (2011) Revisiting the concept of cancer stem cells in prostate cancer. Oncogene 30: 1261-1271.
4. Goldstein AS, Stoyanova T, Witte ON, (2010) Primitive origins of prostate cancer: in vivo evidence for prostate-regenerating cells and prostate cancer-initiating cells. Mol Oncol 4: 385-396.
5. Tang DG, Patrawala L, Calhoun T, Bhatia B, Choy G, et al. (2007) Prostate cancer stem/progenitor cells: identification, characterization, and implications. Mol Carcinog 46: 1-14.
6. Visvader JE, (2011) Cells of origin in cancer. Nature 469: 314-322.
7. Maitland NJ, Collins A, (2005) A tumour stem cell hypothesis for the origins of prostate cancer. BJU Int 96: 1219-1223.
8. Moscatelli D, Wilson EL, (2010) PINing down the origin of prostate cancer. Sci Transl Med 2: 43ps38.
9. Korsten H, Ziel-van der Made A, Ma X, van der Kwast T, Trapman J, (2009) Accumulating progenitor cells in the luminal epithelial cell layer are candidate tumor initiating cells in a Pten knockout mouse prostate cancer model. PLoS One 4: e5662.
10. Wang X, Kruithof-de Julio M, Economides KD, Walker D, Yu H, et al. (2009) A luminal epithelial stem cell that is a cell of origin for prostate cancer. Nature 461: 495-500.
11. Kurita T, Medina RT, Mills AA, Cunha GR, (2004) Role of p63 and basal cells in the prostate. Development 131: 4955-4964.
12. Lawson DA, Zong Y, Memarzadeh S, Xin L, Huang J, et al. (2010) Basal epithelial stem cells are efficient targets for prostate cancer initiation. Proc Natl Acad Sci U S A 107: 2610-2615.
13. Goldstein AS, Huang J, Guo C, Garraway IP, Witte ON, (2010) Identification of a cell of origin for human prostate cancer. Science 329: 568-571.
14. Choi N, Zhang B, Zhang L, Ittmann M, Xin L, (2012) Adult Murine Prostate Basal and Luminal Cells Are Self-Sustained Lineages that Can Both Serve as Targets for Prostate Cancer Initiation. Cancer Cell 21: 253-265.
15. Sarker D, Reid AH, Yap TA, de Bono JS, (2009) Targeting the PI3K/AKT pathway for the treatment of prostate cancer. Clin Cancer Res 15: 4799-4805.
16. McMenamin ME, Soung P, Perera S, Kaplan I, Loda M, et al. (1999) Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage. Cancer Res 59: 4291-4296.
17. Wang S, Gao J, Lei Q, Rozengurt N, Pritchard C, et al. (2003) Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell 4: 209-221.
18. Wang S, Garcia AJ, Wu M, Lawson DA, Witte ON, et al. (2006) Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation. Proc Natl Acad Sci U S A 103: 1480-1485.
19. Mulholland DJ, Xin L, Morim A, Lawson D, Witte O, et al. (2009) Lin-Sca-1+CD49fhigh stem/progenitors are tumor-initiating cells in the Pten-null prostate cancer model. Cancer Res 69: 8555-8562.
20. Mulholland DJ, Tran LM, Li Y, Cai H, Morim A, et al. (2011) Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth. Cancer Cell 19: 792-804.
21. Tsujimura A, Koikawa Y, Salm S, Takao T, Coetzee S, et al. (2002) Proximal location of mouse prostate epithelial stem cells: a model of prostatic homeostasis. J Cell Biol 157: 1257-1265.
22. Wang XD, Wang BE, Soriano R, Zha J, Zhang Z, et al. (2007) Expression profiling of the mouse prostate after castration and hormone replacement: implication of H-cadherin in prostate tumorigenesis. Differentiation 75: 219-234.
23. Carver BS, Chapinski C, Wongvipat J, Hieronymus H, Chen Y, et al. (2011) Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer. Cancer Cell 19: 575-586.
24. Swart GW, (2002) Activated leukocyte cell adhesion molecule (CD166/ALCAM): developmental and mechanistic aspects of cell clustering and cell migration. Eur J Cell Biol 81: 313-321.
25. van Kempen LC, Nelissen JM, Degen WG, Torensma R, Weidle UH, et al. (2001) Molecular basis for the homophilic activated leukocyte cell adhesion molecule (ALCAM)-ALCAM interaction. J Biol Chem 276: 25783-25790.
26. Lawson DA, Xin L, Lukacs RU, Cheng D, Witte ON, (2007) Isolation and functional characterization of murine prostate stem cells. Proc Natl Acad Sci U S A 104: 181-186.
27. Ofori-Acquah SF, King JA, (2008) Activated leukocyte cell adhesion molecule: a new paradox in cancer. Transl Res 151: 122-128.
28. Garraway IP, Sun W, Tran CP, Perner S, Zhang B, et al. (2010) Human prostate sphere-forming cells represent a subset of basal epithelial cells capable of glandular regeneration in vivo. Prostate 70: 491-501.
29. Goldstein AS, Lawson DA, Cheng D, Sun W, Garraway IP, et al. (2008) Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics. Proc Natl Acad Sci U S A 105: 20882-20887.
30. Liu C, Kelnar K, Liu B, Chen X, Calhoun-Davis T, et al. (2011) The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med 17: 211-215.
31. Leong KG, Wang BE, Johnson L, Gao WQ, (2008) Generation of a prostate from a single adult stem cell. Nature 456: 804-808.
32. Burger PE, Gupta R, Xiong X, Ontiveros CS, Salm SN, et al. (2009) High aldehyde dehydrogenase activity: a novel functional marker of murine prostate stem/progenitor cells. Stem Cells 27: 2220-2228.
33. Richardson GD, Robson CN, Lang SH, Neal DE, Maitland NJ, et al. (2004) CD133, a novel marker for human prostatic epithelial stem cells. J Cell Sci 117: 3539-3545.
34. Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, et al. (2010) Integrative genomic profiling of human prostate cancer. Cancer Cell 18: 11-22.
35. Weiner JA, Koo SJ, Nicolas S, Fraboulet S, Pfaff SL, et al. (2004) Axon fasciculation defects and retinal dysplasias in mice lacking the immunoglobulin superfamily adhesion molecule BEN/ALCAM/SC1. Mol Cell Neurosci 27: 59-69.
36. van Kempen LC, van den Oord JJ, van Muijen GN, Weidle UH, Bloemers HP, et al. (2000) Activated leukocyte cell adhesion molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin. Am J Pathol 156: 769-774.
37. King JA, Tan F, Mbeunkui F, Chambers Z, Cantrell S, et al. (2010) Mechanisms of transcriptional regulation and prognostic significance of activated leukocyte cell adhesion molecule in cancer. Mol Cancer 9: 266.
38. Kristiansen G, Pilarsky C, Wissmann C, Kaiser S, Bruemmendorf T, et al. (2005) Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival. J Pathol 205: 359-376.
39. Mezzanzanica D, Fabbi M, Bagnoli M, Staurengo S, Losa M, et al. (2008) Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patients. Clin Cancer Res 14: 1726-1733.
40. Kahlert C, Weber H, Mogler C, Bergmann F, Schirmacher P, et al. (2009) Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse. Br J Cancer 101: 457-464.
41. Weichert W, Knosel T, Bellach J, Dietel M, Kristiansen G, (2004) ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival. J Clin Pathol 57: 1160-1164.
42. Sawhney M, Matta A, Macha MA, Kaur J, DattaGupta S, et al. (2009) Cytoplasmic accumulation of activated leukocyte cell adhesion molecule is a predictor of disease progression and reduced survival in oral cancer patients. Int J Cancer 124: 2098-2105.
43. Ishigami S, Ueno S, Arigami T, Arima H, Uchikado Y, et al. (2011) Clinical implication of CD166 expression in gastric cancer. J Surg Oncol 103: 57-61.
44. Liao CP, Adisetiyo H, Liang M, Roy-Burman P, (2010) Cancer-associated fibroblasts enhance the gland-forming capability of prostate cancer stem cells. Cancer Res 70: 7294-7303.
45. De Marzo AM, Nelson WG, Bieberich CJ, Yegnasubramanian S, (2010) Prostate cancer: New answers prompt new questions regarding cell of origin. Nat Rev Urol 7: 650-652.
46. Sato C, Matsuda T, Kitajima K, (2002) Neuronal differentiation-dependent expression of the disialic acid epitope on CD166 and its involvement in neurite formation in Neuro2A cells. J Biol Chem 277: 45299-45305.
47. Lu TL, Chang JL, Liang CC, You LR, Chen CM, (2007) Tumor spectrum, tumor latency and tumor incidence of the Pten-deficient mice. PLoS One 2: e1237.
48. Abou-Kheir WG, Hynes PG, Martin PL, Pierce R, Kelly K, (2010) Characterizing the contribution of stem/progenitor cells to tumorigenesis in the Pten-/-TP53-/- prostate cancer model. Stem Cells 28: 2129-2140.
49. Rajasekhar VK, Studer L, Gerald W, Socci ND, Scher HI, (2011) Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-kappaB signalling. Nat Commun 2: 162.
50. Chao MP, Alizadeh AA, Tang C, Jan M, Weissman-Tsukamoto R, et al. (2011) Therapeutic antibody targeting of CD47 eliminates human acute lymphoblastic leukemia. Cancer Res 71: 1374-1384.
51. Lunter PC, van Kilsdonk JW, van Beek H, Cornelissen IM, Bergers M, et al. (2005) Activated leukocyte cell adhesion molecule (ALCAM/CD166/MEMD), a novel actor in invasive growth, controls matrix metalloproteinase activity. Cancer Res 65: 8801-8808.
52. Wiiger MT, Gehrken HB, Fodstad O, Maelandsmo GM, Andersson Y, (2010) A novel human recombinant single-chain antibody targeting CD166/ALCAM inhibits cancer cell invasion in vitro and in vivo tumour growth. Cancer Immunol Immunother 59: 1665-1674.
53. Hart LS, El-Deiry WS, (2008) Invincible, but not invisible: imaging approaches toward in vivo detection of cancer stem cells. J Clin Oncol 26: 2901-2910.
54. Wang CH, Chiou SH, Chou CP, Chen YC, Huang YJ, et al. (2011) Photothermolysis of glioblastoma stem-like cells targeted by carbon nanotubes conjugated with CD133 monoclonal antibody. Nanomedicine 7: 69-79.
55. Roth A, Drummond DC, Conrad F, Hayes ME, Kirpotin DB, et al. (2007) Anti-CD166 single chain antibody-mediated intracellular delivery of liposomal drugs to prostate cancer cells. Mol Cancer Ther 6: 2737-2746.
56. Lukacs RU, Goldstein AS, Lawson DA, Cheng D, Witte ON, (2010) Isolation, cultivation and characterization of adult murine prostate stem cells. Nat Protoc 5: 702-713.
57. Xin L, Lukacs RU, Lawson DA, Cheng D, Witte ON, (2007) Self-renewal and multilineage differentiation in vitro from murine prostate stem cells. Stem Cells 25: 2760-2769.
58. Narita S, So A, Ettinger S, Hayashi N, Muramaki M, et al. (2008) GLI2 knockdown using an antisense oligonucleotide induces apoptosis and chemosensitizes cells to paclitaxel in androgen-independent prostate cancer. Clin Cancer Res 14: 5769-5777.
59. Goldstein AS, Drake JM, Burnes DL, Finley DS, Zhang H, et al. (2011) Purification and direct transformation of epithelial progenitor cells from primary human prostate. Nat Protoc 6: 656-667.